within Pharmacolibrary.Drugs.N_NervousSystem.N04B_DopaminergicAgents.N04BC05_Pramipexole;

model Pramipexole
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.9,
    Cl = 6.666666666666667e-06,
    adminDuration = 600,
    adminMass = 1.5 / 1000000,
    adminCount = 1,
    Vd = 0.34,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.008,
    Tlag = 10.200000000000001,
    Vdp = 0.172,
    k12 = 2.611111111111111e-05,
    k21 = 2.611111111111111e-05);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Pramipexole</td></tr><tr><td>ATC code:</td><td>N04BC05</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>1.5</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>340</td><td>L</td></tr>
    <tr><td>clearance:</td><td>24</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Pramipexole is a non-ergoline dopamine agonist indicated for the treatment of Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome (RLS). It is approved and used clinically today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects after oral administration.</p><h4>References</h4><ol><li><p>Soto, E, et al., &amp; Trocóniz, IF (2010). Population in vitro-in vivo correlation model for pramipexole slow-release oral formulations. <i>Pharmaceutical research</i> 27(2) 340–349. DOI:<a href=\"https://doi.org/10.1007/s11095-009-0027-8\">10.1007/s11095-009-0027-8</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20039105/\">https://pubmed.ncbi.nlm.nih.gov/20039105</a></p></li><li><p>You, X, et al., &amp; Lin, C (2020). Development of a Physiologically Based Pharmacokinetic Model for Prediction of Pramipexole Pharmacokinetics in Parkinson&#x27;s Disease Patients With Renal Impairment. <i>Journal of clinical pharmacology</i> 60(8) 999–1010. DOI:<a href=\"https://doi.org/10.1002/jcph.1593\">10.1002/jcph.1593</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32090332/\">https://pubmed.ncbi.nlm.nih.gov/32090332</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.N.N04BC05 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Pramipexole;
